ARCHIVES

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Michael Link Elected ASCO President.

January 15, 2010

Obey Surprises Everyone, Including Himself, And Plugs For More Money For NCI, NHLBI

March 7, 1980

Wider Use Of Adjuvant Chemotherapy Recommended By NIH Consensus Panel.

November 10, 2000

Conversation With The Cancer Letter: What $34,000 Per Patient Buys In Lung-MAP

June 20, 2014

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006